Tweet Facebook Mail Clinical outlook: Oncologist Dr Sam Harris said he was confident the success of the trial will mean Cemiplimab will eventually be available via the Pharmaceutical Benefits Scheme. Photo: BENDIGO HEALTH Share Share this on Facebook Twitter LinkedIn Send this by Email Copy link WhatsApp